Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Depreciation & Amortization (CF) (2023 - 2025)

Historic Depreciation & Amortization (CF) for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $534000.0.

  • Nuvation Bio's Depreciation & Amortization (CF) rose 22962.96% to $534000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 17668.59%. This contributed to the annual value of $700000.0 for FY2024, which is 21531.53% up from last year.
  • As of Q3 2025, Nuvation Bio's Depreciation & Amortization (CF) stood at $534000.0, which was up 22962.96% from $356000.0 recorded in Q2 2025.
  • Nuvation Bio's Depreciation & Amortization (CF)'s 5-year high stood at $534000.0 during Q3 2025, with a 5-year trough of $55000.0 in Q3 2023.
  • In the last 3 years, Nuvation Bio's Depreciation & Amortization (CF) had a median value of $162000.0 in 2024 and averaged $192909.1.
  • As far as peak fluctuations go, Nuvation Bio's Depreciation & Amortization (CF) soared by 357.14% in 2024, and later surged by 43448.28% in 2025.
  • Over the past 3 years, Nuvation Bio's Depreciation & Amortization (CF) (Quarter) stood at $55000.0 in 2023, then skyrocketed by 329.09% to $236000.0 in 2024, then skyrocketed by 126.27% to $534000.0 in 2025.
  • Its last three reported values are $534000.0 in Q3 2025, $356000.0 for Q2 2025, and $310000.0 during Q1 2025.